Ellenzweig的动态

?? Today is a new day that #science and the #business fabric gather to search for a new future! ?? MIRRI-ERIC, will participate in the Biotech Flash Talks and Speed Meetings. The presentation will cover: the Role of MIRRI-ERIC, Associated European Projects and the Connection with the Local Economy. This initiative of #EXPOBIOTEC – Braga #Biotechnology Week 2024 aims to promote the interconnection between science and companies and, at the same time, seek new models of collaboration and innovation. ???? #Biotech #MIRRIERIC #EXPOBIOTEC2024 #BragaBiotechWeek

Today is a new day that #science and #business fabric gather to search for a new future! This Thursday, several companies will gather in the Forum Braga Congress Room for different rounds of Biotech Flash Talks and Speed Meetings. This initiative of #EXPOBIOTEC – Braga #Biotechnology Week 2024 aims to promote the interconnection between science and companies and, at the same time, seek new models of collaboration and innovation. The information is all here: https://lnkd.in/dDAcRiT8

Over the next 7 days, I'll be sharing 7 transformative insights for professionals in biotech, focusing on how to revolutionize bioprocess development. Stay tuned to challenge the status quo and explore bold strategies that could redefine your approach to innovation! #biotech #innovation Let’s start today with my insight 1/7: ?? Early Engagement and Real-Time Data Can Transform Your Regulatory Strategy! With the BioLectorXT from Beckman Coulter, you gain access to comprehensive, real-time data on microbial/biological culture and bioprocess conditions. This valuable data can generate robust and detailed documentation, streamlining your interactions with regulatory bodies. Benefit: Online monitoring, pre-calibrated sensors, high-quality, consistent data at your fingertips. ???? Impact: Facilitate early engagement and potentially accelerate your approval process, bringing your innovation to market faster. ??? Want to learn more, come to visit us at ILMAC Lausanne Hall 36, Booth C161! Check out more about the BioLectorXT here: https://lnkd.in/d9iR7gzB #biotech #innovation #cellculture #microbialculture #biologicalculture #regulatoryaffairs #biolectorxt #bioprocess

These are the top biotech and life science companies in Texas - per the 2024 Innovations of Tomorrow report by Texas Healthcare and Bioscience Institute (THBI). Link to the report: https://lnkd.in/gXmQpS6e #markets #innovation #technology

How can we facilitate the flow of scientific breakthroughs and intellectual properties from creators to the broader market and society? This question lies at the heart of the Technology Transfer process, the ultimate goal for companies operating in highly innovative sectors. Our CEO, Luigi Aurisicchio, recently took part in the Life Science TTO Network event: 'PerfeTTO ed Industria: Opportunità e Criticità del Trasferimento Tecnologico.' This gathering brought together various stakeholders in the financing of innovative projects and companies, aiming to formulate policies supporting research spin-offs and foster innovative clusters in the Life Science sector. Luigi's insights highlighted the challenges in Technological Transfer in Italy, emphasizing the critical need for networks and growth opportunities. We believe that innovative biotech companies like ours, equipped with business expertise and cutting-edge research, can play a pivotal role in transforming inventive ideas into therapeutic solutions that benefit patients and healthcare professionals. #lifescience #technologytransfer #biotech #biotechnology #technology #research #innovation

Advances in pharma and biotech are critical for the progression of modern medicine, but at what cost to the environment? In this exclusive video interview with Technology Networks, My Green Lab’s CEO James Connelly discussed why our recently released 2023 Carbon Impact of Biotech and Pharma report is so important, its key findings, and steps that laboratories can take to reduce their carbon emissions. Watch the video here: https://lnkd.in/g7m-UG-A Download the 2023 report here: https://lnkd.in/eC5cUkun

If you missed the 2023 report during the craze of the holidays, check out this interview and take a deeper dive with the report from our friends at My Green Lab. A great resolution for 2024 is reducing the Scope 3 emissions associated with your lab. #SustainableInnovation #Scope3Emissions #Decarbonize

Exciting news! Our CEO will be a panelist at the The Inaugural Phoenix Global Forum 2024, discussing the "Biotechnology Revolution: Advancements, Challenges, and Future Outlook"?today, May 2nd, at 2:30-3:30pm MST. Join us for this crucial conversation shaping the future of healthcare! #Biotechnology #Innovation #RegenerativeMedicine #Healthcare #PhoenixGlobalForum

TUESDAY, January 16th 1:20pm EST REGISTER NOW TO SAVE YOUR PLACE: https://hubs.li/Q02gt-Wq0 Brought to you by Orientation Marketing, hear thought-provoking views from Dan Smithey, PhD, President, CEO & Co-Founder of Serán BioScience and four experienced c-level executives from leading development, technology, manufacturing, and bioprocessing partners. Each is tasked with navigating ever-evolving deal dynamics, complex development, analytical, formulation and manufacturing approaches across many more modalities, and a regulatory landscape forever changed by the pandemic, and racing to keep pace with accelerating innovation. Find out more about this panel here: https://hubs.li/Q02gv0cz0 REGISTER HERE: https://hubs.li/Q02gt-Wq0

We will be speaking at the Symposium for the 2025 Novo Nordisk Challenge Programme on the theme: Heterogeneity in Biomanufacturing On 18 June 2024 the Novo Nordisk Foundation will host a symposium with the aim of bringing together the bioindustrial research community for an exciting ?-day of knowledge sharing and networking. We are pleased that our CSO, Peter Rugbjerg, has been invited as one of the few key speakers to enlighten a broad audience on this exciting theme for the 2025 Challenge Programme. Peter highlights: “It is very exciting that the Novo Nordisk Foundation chose heterogeneity as topic for its Challenge Programme. There are many challenging areas that the industry will benefit from seeing uncovered, one prime example being deep single-cell detection and diagnosis to enable our basic understanding. I look forward to sharing our perspectives and meeting researchers from across the community.” Having developed groundbreaking technology to address heterogeneity in biomanufacturing, Peter is seen as a leading expert in the field. We look forward to engaging with research and industry partners during the Symposium forging new paths and driving innovation forward. #Biomanufacturing #Bioproduction #Synbio #fermentation #bioprocess #ResearchInnovation #Sustainability #GreenTransition